Literature DB >> 14551693

[Electrophysiological impairment profile of patients with Wilson's disease].

W Hermann1, T Villmann, A Wagner.   

Abstract

In addition to hepatic and extrapyramidal motor clinical symptoms, Wilson's disease patients also exhibit subclinical disorders of other central nervous pathways. In this study, an impairment profile is described by means of eight electrophysiological tests (EAEP, MSEP, TSEP, T-VEP, MEP, EEG, heart frequency variability, and SSR) for 37 patients (28 with neurological, nine with tnon-neurological form) undergoing long-term drug therapy. The occurrence in 64.3% of a delayed wave III and/or IPL III-V prolongation in patients with the neurological form makes pathological FAEP the most common form of the disorder, followed by disorders in MSEP, TSEP, MEP, and T-VEP. Patients with the non-neurological form usually have normal values, although latency prolongations occur in isolated cases. The range of evoked potential findings is characterised primarily by latency prolongations, i.e. a demyelinising impairment type, and significant losses of potential hardly occur (except in the MEP). The electrophysiological impairment profile does not include EEG changes or vegetative disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14551693     DOI: 10.1007/s00115-003-1564-8

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  25 in total

1.  Comparison of MRI, EEG, EPs and ECD-SPECT in Wilson's disease.

Authors:  M Giagheddu; G Tamburini; M Piga; P Tacconi; A Giagheddu; A Serra; P Siotto; L Satta; L Demelia; F Marrosu
Journal:  Acta Neurol Scand       Date:  2001-02       Impact factor: 3.209

Review 2.  [Wilson's disease. The making of a diagnosis by conventional and molecular biology methods].

Authors:  T Maier-Dobersberger
Journal:  Dtsch Med Wochenschr       Date:  1999-04-23       Impact factor: 0.628

Review 3.  [Wilson's disease with primary CNS manifestation--current status in diagnosis and therapy].

Authors:  J Willeit; S G Kiechl; G Birbamer; C Schmidauer; S Felber; F Aichner; L Saltvari; R Metzler; G Judmaier
Journal:  Fortschr Neurol Psychiatr       Date:  1992-06       Impact factor: 0.752

4.  Wilson's disease: normalisation of cortically evoked motor responses with treatment.

Authors:  B U Meyer; T C Britton; R Benecke
Journal:  J Neurol       Date:  1991-09       Impact factor: 4.849

5.  Evoked potentials in assessment and follow-up of patients with Wilson's disease.

Authors:  G Grimm; W Oder; L Prayer; P Ferenci; C Madl
Journal:  Lancet       Date:  1990-10-20       Impact factor: 79.321

Review 6.  Wilson's disease.

Authors:  C D Marsden
Journal:  Q J Med       Date:  1987-12

7.  Abnormal conduction in corticospinal pathways in Wilson's disease: investigation of nine cases with magnetic brain stimulation.

Authors:  B U Meyer; T C Britton; C Bischoff; J Machetanz; R Benecke; B Conrad
Journal:  Mov Disord       Date:  1991       Impact factor: 10.338

8.  The diagnostic value of multi-modality evoked potentials in Wilson's disease.

Authors:  G Arendt; H Hefter; W Stremmel; G Strohmeyer
Journal:  Electromyogr Clin Neurophysiol       Date:  1994 Apr-May

Review 9.  Wilson's disease and epilepsy.

Authors:  T R Dening; G E Berrios; J M Walshe
Journal:  Brain       Date:  1988-10       Impact factor: 13.501

10.  Wilson disease: clinical presentation, treatment, and survival.

Authors:  W Stremmel; K W Meyerrose; C Niederau; H Hefter; G Kreuzpaintner; G Strohmeyer
Journal:  Ann Intern Med       Date:  1991-11-01       Impact factor: 25.391

View more
  4 in total

1.  [Wilson's disease and Westphal-Strümpell pseudosclerosis: conceptual history in German-speaking countries].

Authors:  P Boide; A Wagner; H Steinberg
Journal:  Nervenarzt       Date:  2011-10       Impact factor: 1.214

2.  [Classification of Wilson's disease based on neurophysiological parameters].

Authors:  W Hermann; P Günther; A Wagner; T Villmann
Journal:  Nervenarzt       Date:  2005-06       Impact factor: 1.214

3.  Profound midbrain atrophy in patients with Wilson's disease and neurological symptoms?

Authors:  K Strecker; J P Schneider; H Barthel; W Hermann; F Wegner; A Wagner; J Schwarz; O Sabri; C Zimmer
Journal:  J Neurol       Date:  2006-04-10       Impact factor: 4.849

4.  Fine motor skills disorders in the course of Wilson's disease.

Authors:  Peter Albrecht Günther; Hans-Juergen Kühn; Thomas Villmann; Wieland Hermann
Journal:  Ann Indian Acad Neurol       Date:  2009-01       Impact factor: 1.383

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.